CheckMyRecalls

Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride…

Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules

Published
7 May 2025
Units affected
1190 Bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Brand / company
Preferred Pharmaceuticals, Inc.
Codes / lots
Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
Distribution
Nationwide in the US
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.